Back to Results
First PageMeta Content
Circulatory system / Valvular heart disease / Mitral regurgitation / Heart valve repair / Mitral valve annuloplasty / Mitral valve / Heart valve / Regurgitation / Mitral annulus / Medicine / Cardiac surgery / Cardiology


FOR IMMEDIATE RELEASE Mitralign Completes Enrollment in EU Study for its Novel Catheterbased Valve Repair Device Company to seek CE Mark for new first-line percutaneous treatment of functional mitral regurgitation TEWKS
Add to Reading List

Document Date: 2014-04-08 14:11:00

Open Document

File Size: 324,06 KB

Share Result on Facebook

City

TEWKSBURY / Boston / /

Company

Novel Catheterbased Valve Repair Device Company / Mitralign Inc. / /

Continent

Europe / /

Country

United States / /

/

Event

FDA Phase / /

IndustryTerm

catheter-based valve repair technology / /

MedicalCondition

functional mitral regurgitation TEWKSBURY / valve disease / valvular heart disease / cardiomyopathy / heart enlargement / mitral regurgitation / mitral insufficiency / severe functional mitral regurgitation / severe heart disease / heart failure / heart attack / functional mitral regurgitation / functional mitral regurgitation Mitral valve regurgitation / /

MedicalTreatment

catheter / catheters / surgery / /

Organization

Universitätsklinikum Bonn in Germany / European Commission / European Union / /

Person

Rick Geoffrion / Georg Nickenig / David Schleifer / /

Position

Director / chief executive officer / lead investigator and professor / /

Product

Mitralign System / European Union / /

ProvinceOrState

Massachusetts / /

Technology

catheter-based valve repair technology / /

URL

www.mitralign.com / /

SocialTag